Maimonides Medical Center
Also known as: Antonios Likourezos | Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY, USA | Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló | I.U. Fundación H.A. Barceló - U. Maimónides - U. Nacional Arturo Jauretche | Jocelyne Karam | Maimonides | Maimonides Biomedical Research Institute of Cordoba | Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital | Maimonides Medical Center | MAIMONIDES MEDICAL CENTER, 4802, 10TH AVENUE, BROOKLYN, NY-11219 | Maimonides Medical Center Dept. of Psychiatry Chairman | Maimonides University | Minimally Invasive Surgery -Fellowship Director | Pablo Pérez Martínez | Universidad Maimónides | Universidad Maimónides - Hospital Universitario Austral
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1977Last known activity
Nov 30, 2025
Timeline
1910s
- Jan 1, 1911
Maimonides Medical Center— Founded
Drugs by trial phase (45 distinct, 61 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acute Pain
- Arthritis
- Atrial Fibrillation
- Atrial Flutter
- Attention Deficit Disorder with Hyperactivity
- Cardio-Renal Syndrome
- Cardiovascular Diseases
- Coronary Disease
- Coronavirus Infections
- Death, Sudden
- Death, Sudden, Cardiac
- Dwarfism
- Emergencies
- Femoral Fractures
- Femoral Neck Fractures
- Fractures, Bone
- Heart Diseases
- Hernia
- Hernia, Abdominal
- Hip Fractures
- Hypertension
- Hypertension, Pregnancy-Induced
- Hypothyroidism
- Infertility
- Infertility, Female
- Infertility, Male
- Leiomyoma
- Musculoskeletal Pain
- Myocardial Infarction
- Myocardial Ischemia
- Polycystic Ovary Syndrome
- Postoperative Pain
- Pre-Eclampsia
- Rib Fractures
- Severe Acute Respiratory Syndrome
- Shoulder Pain
- Syndrome
- Ventricular Fibrillation
- Vitamin D Deficiency
Recent trials (50)
- NCT07237048OfficialPhase 2/Phase 3Nov 30, 2025
- NCT07237048Lead sponsorPhase 2/Phase 3Nov 30, 2025
- NCT07237048Sponsor investigatorPhase 2/Phase 3Nov 30, 2025
- NCT06752759Sponsor investigatorPhase 3Oct 16, 2024
- NCT06752759Lead sponsorPhase 3Oct 16, 2024
- NCT06498908Sponsor investigatorPhase 3May 15, 2024
- NCT06498908Lead sponsorPhase 3May 15, 2024
- NCT06364540OfficialPhase 4May 1, 2024
- NCT06364540Lead sponsorPhase 4May 1, 2024
- NCT06364540Sponsor investigatorPhase 4May 1, 2024
- NCT06107725Lead sponsorPhase 2/Phase 3Nov 1, 2023
- NCT06107725Reponsible party - principal investigatorPhase 2/Phase 3Nov 1, 2023
- NCT05823363Lead sponsorPhase 4Apr 10, 2023
- NCT05615948Overall official - principal investigatorPhase 4Dec 6, 2022
- NCT05615948Lead sponsorPhase 4Dec 6, 2022
Details
- Founded
- Brooklyn, NY, US Jan 1, 1911
- Last known activity
- Nov 30, 2025